AI Summary Bariatric surgery and endoscopic sleeve gastroplasty (ESG) both promote sustained weight loss that may reduce liver fat and improve MASLD or MASH in selected patients.
Medically reviewed.
Bariatric and endoscopic therapies are weight-loss treatments — including bariatric surgery and endoscopic sleeve gastroplasty (ESG) — used to promote significant, sustained weight loss in people with obesity. In selected patients with metabolic dysfunction-associated steatotic liver disease (MASLD) or metabolic dysfunction-associated steatohepatitis (MASH), these procedures may help reduce liver fat, ease inflammation, and improve fibrosis risk factors alongside broader metabolic health.
This page explains how bariatric surgery and ESG work, who may benefit, and what to expect during treatment and follow-up. You can also connect with a liver specialist to discuss whether one of these therapies fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
BARIATRIC & ENDOSCOPIC THERAPIES OVERVIEW
Bariatric and endoscopic therapies are procedures that promote significant and sustained weight loss by limiting food intake, whether through surgery or an incisionless endoscopic approach. Care built around these procedures typically combines the procedure with lifestyle changes and regular monitoring, and treatment plans are personalized based on a person's weight, liver disease stage, overall health, and individual needs.
You can explore the individual bariatric and endoscopic therapies below and learn how they may support weight loss, metabolic health, and — in selected patients — liver fat and fibrosis improvement. Because eligibility depends on your specific diagnosis and health history, connecting with a liver specialist can help you understand which option fits your care plan.
Bariatric surgery is a group of surgical procedures, including sleeve gastrectomy and Roux-en-Y gastric bypass, that reduce stomach capacity to promote substantial and sustained weight loss. In selected patients with MASLD or MASH, it may help reduce liver fat, inflammation, and fibrosis risk factors alongside broader metabolic improvement.
Explore this therapy:
ESG is a minimally invasive, incision-free procedure that uses an endoscope to place sutures inside the stomach and reduce its volume. It promotes earlier fullness after meals and gradual, sustained weight loss, and may be considered for people seeking a less invasive alternative to bariatric surgery.
Explore this therapy:
Providers may consider bariatric surgery or ESG for adults with severe obesity that hasn't responded adequately to lifestyle changes, obesity-related conditions such as type 2 diabetes or sleep apnea, or MASLD/MASH associated with excess body weight.
DIET & LIFESTYLE SUPPORT
Bariatric surgery and ESG work best when combined with lifestyle changes. Nutrition, physical activity, weight management, and control of related metabolic conditions all support the liver health benefits these procedures can offer.
A structured, high-protein, liver-friendly diet with portion control supports the weight loss these procedures promote and helps protect liver health afterward.
Bariatric surgery and ESG both require ongoing dietary counseling and, for surgery, lifelong vitamin and mineral supplementation to prevent nutritional deficiencies.
Regular physical activity supports metabolic health and helps sustain weight loss and liver benefits alongside the procedure.
A nutrition bar designed for liver health can be a simple, consistent way to help meet daily protein and energy goals during recovery and long-term follow-up.
Explore Liver Health Nutrition Bars
COMPARING YOUR OPTIONS
Bariatric surgery is a permanent, surgical intervention intended to produce durable weight loss over years, with a short hospital stay and lifelong follow-up. ESG is a minimally invasive, incision-free endoscopic procedure, usually done with same-day or brief observation recovery, that may appeal to people seeking a less invasive alternative or who do not meet surgical criteria.
Bariatric surgery and endoscopic sleeve gastroplasty (ESG) both promote weight loss that can improve liver fat, inflammation, and metabolic health, but they differ in invasiveness, permanence, and who they typically suit.
Bariatric surgery reduces stomach capacity through procedures such as sleeve gastrectomy or Roux-en-Y gastric bypass. It requires a short hospital stay and is considered a permanent, long-term intervention with lifelong follow-up.
ESG uses an endoscope to place sutures inside the stomach, reducing its volume without external incisions. Most patients return home the same day or after a brief observation period.
Both approaches reduce liver fat accumulation and may improve or slow progression of MASLD and MASH. Neither replaces the need for lifelong dietary change and monitoring.
TREATMENT MONITORING
Regular monitoring helps your healthcare provider evaluate how your body and liver are responding to bariatric surgery or ESG and track changes over time. Follow-up care may include blood tests, imaging, and nutritional checks alongside routine weight and metabolic monitoring.
Liver function tests track enzymes and other markers that show how your liver is responding to weight loss and help flag any changes early.
Providers use metabolic markers alongside liver tests to track liver fat, insulin resistance, and related risk factors over time.
Imaging and, in selected cases, biopsy can assess liver fat and fibrosis directly and help guide long-term follow-up after the procedure.
After bariatric surgery, lifelong vitamin and mineral monitoring is needed to catch nutritional deficiencies early; ESG also calls for ongoing nutritional follow-up.
Only a qualified healthcare provider can adjust your treatment plan based on your test results and health history.
COMMON QUESTIONS
Bariatric and endoscopic therapies are weight-loss procedures used to treat obesity, including in people with metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis (MASH). Bariatric surgery includes procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass, while endoscopic sleeve gastroplasty (ESG) is a minimally invasive, incision-free alternative. Both reduce stomach capacity to promote weight loss that can improve liver fat and metabolic health. Talk with your liver specialist to see if either fits your treatment plan.
Both approaches reduce how much food the stomach can hold. Bariatric surgery surgically reduces stomach size through procedures like sleeve gastrectomy or gastric bypass. ESG uses an endoscope to place sutures inside the stomach, shrinking its volume without incisions. Both promote earlier fullness, substantial weight loss, and improved insulin sensitivity, which can reduce liver fat accumulation over time.
Providers may consider these therapies for adults with severe obesity that hasn't responded adequately to lifestyle changes, obesity-related conditions such as type 2 diabetes, hypertension, or sleep apnea, or MASLD/MASH associated with excess body weight. ESG may particularly suit people seeking a less invasive alternative to surgery. Eligibility depends on a full medical, nutritional, and psychological evaluation. Only a qualified healthcare provider can determine which option, if any, is right for you.
Bariatric surgery is a permanent, long-term intervention: most patients need a short hospital stay, followed by gradual return to diet and activity, with lifelong follow-up to maintain results. ESG is less invasive, and most patients return home the same day or after a brief observation period, though it also requires long-term dietary and lifestyle commitment to sustain weight loss and metabolic benefits.
Common risks for bariatric surgery include nausea or vomiting, nutritional deficiencies, abdominal discomfort, surgical complications, and the need for lifelong dietary monitoring. ESG's common risks are typically milder and include nausea, abdominal pain or cramping, vomiting, temporary fatigue, and acid reflux or indigestion. Your healthcare provider will monitor you regularly and can help manage any side effects that arise.
No, neither procedure replaces the need for lifestyle change. Bariatric surgery requires permanent dietary changes, high-protein nutrition, regular physical activity, and lifelong vitamin and mineral supplementation. ESG similarly calls for ongoing dietary counseling, exercise, and behavioral changes. Both are intended to work alongside, not instead of, sustained lifestyle habits to maintain weight loss and liver health benefits.
In selected patients with MASLD or MASH, both bariatric surgery and ESG may help reduce liver fat accumulation and improve or slow progression of liver disease. These liver benefits typically occur alongside the substantial weight loss and metabolic improvement the procedures promote, rather than through a separate liver-specific mechanism. Your healthcare provider can explain how this applies to your diagnosis.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
